Christopher Robert Entwisle, MD
Gastroenterology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 4 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
12 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Entwisle’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A95045 · Current
Licensed to practise in California · since 2006 · expires 2027-11-30 · New York Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$163,336
Medicare paid this office $163,336 for 710 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 276 | $42,532 | $114 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 129 | $29,726 | $230 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 41 | $19,600 | $478 |
| New patient visit (45+ min) | 86 | $11,499 | $134 |
| Short return visit (20+ min) | 113 | $9,997 | $85 |
See all 15 services
| Return visit (30+ min) | 276 | $42,532 | $114 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 129 | $29,726 | $230 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 41 | $19,600 | $478 |
| New patient visit (45+ min) | 86 | $11,499 | $134 |
| Short return visit (20+ min) | 113 | $9,997 | $85 |
| New patient visit (30+ min) | 94 | $8,826 | $94 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 111 | $8,445 | $76 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 26 | $4,968 | $191 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 23 | $4,578 | $199 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $2,821 | $104 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $2,755 | $153 |
| Biopsy of large bowel using a flexible endoscope | 26 | $2,755 | $106 |
| Long return visit (40+ min) | 13 | $2,267 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $1,606 | $70 |
| New patient visit (15+ min) | 14 | $778 | $56 |
Procedures Medicare counted
| Colonoscopy | 85 | More than 76% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 83 | More than 73% of doctors who do this |
Who their Medicare patients are
710 Original Medicare patients in 2024. Average age 74 · Under 65 5% · 85 and older 10% · Women 58% · Also on Medicaid 9% · Health risk score 1.19. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 73% · Chronic kidney disease 25% · Coronary heart disease 24% · Diabetes 23% · Cancer 17% · Atrial fibrillation 17% · Depression 16% · COPD 14% · Heart failure 12% · Stroke 7% · Dementia 5%.
The office billed $1,194,865, Medicare allowed $208,041 and paid $163,336; for 1,173 services of 24 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 710 | 1,173 | 74 | 1.19 | $1,194,865 | $163,336 |
| 2023 | 646 | 1,179 | 74 | 1.21 | $1,053,657 | $143,678 |
| 2022 | 633 | 1,289 | 74 | 1.13 | $1,182,853 | $155,883 |
| 2021 | 656 | 1,391 | 74 | 1.23 | $1,176,788 | $171,838 |
| 2020 | 604 | 1,369 | 74 | 1.38 | $1,179,879 | $146,861 |
| 2019 | 706 | 1,749 | 74 | 1.29 | $1,432,739 | $182,121 |
| 2018 | 664 | 1,716 | 74 | 1.37 | $1,229,543 | $167,506 |
| 2017 | 571 | 1,688 | 74 | 1.24 | $1,112,415 | $165,774 |
| 2016 | 601 | 1,811 | 74 | 1.49 | $1,081,157 | $170,920 |
| 2015 | 567 | 1,857 | 74 | 1.55 | $857,505 | $176,007 |
| 2014 | 545 | 2,047 | 74 | 1.57 | $782,749 | $191,711 |
| 2013 | 573 | 2,348 | 74 | 1.59 | $799,007 | $216,097 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Return visit (30+ min) | 259 | $39,834 | $112 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 121 | $26,528 | $219 |
| New patient visit (45+ min) | 92 | $13,669 | $149 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 83 | $7,066 | $85 |
| New patient visit (30+ min) | 75 | $6,907 | $92 |
| Short return visit (20+ min) | 85 | $6,856 | $75 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $5,801 | $105 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $5,381 | $154 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 26 | $5,176 | $199 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 25 | $4,919 | $197 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $4,848 | $69 |
| Biopsy of large bowel using a flexible endoscope | 43 | $4,724 | $110 |
| Long return visit (40+ min) | 24 | $4,144 | $166 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,610 | $107 |
| New patient visit (15+ min) | 20 | $878 | $44 |
2022: 14 services
| Return visit (30+ min) | 282 | $46,031 | $113 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 146 | $29,888 | $205 |
| New patient visit (45+ min) | 98 | $15,013 | $153 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 116 | $9,413 | $80 |
| Short return visit (20+ min) | 90 | $7,458 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $7,241 | $91 |
| New patient visit (30+ min) | 63 | $6,782 | $108 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $6,152 | $176 |
| Biopsy of large bowel using a flexible endoscope | 63 | $5,536 | $88 |
| Long return visit (40+ min) | 22 | $4,418 | $164 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 15 | $3,081 | $205 |
| New patient visit (15+ min) | 36 | $2,789 | $77 |
| Diagnostic exam of large bowel using a flexible endoscope | 20 | $2,700 | $135 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $2,276 | $63 |
2021: 17 services
| Return visit (30+ min) | 272 | $50,594 | $127 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 103 | $23,296 | $226 |
| New patient visit (45+ min) | 89 | $14,632 | $164 |
| Short return visit (20+ min) | 133 | $12,358 | $85 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 123 | $9,526 | $77 |
| New patient visit (30+ min) | 78 | $9,232 | $118 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $7,217 | $94 |
| Biopsy of large bowel using a flexible endoscope | 57 | $6,171 | $108 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,980 | $176 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 27 | $5,736 | $212 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 21 | $4,358 | $208 |
| New patient visit (15+ min) | 53 | $4,204 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $3,836 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,882 | $125 |
| Diagnostic exam of large bowel using a flexible endoscope | 18 | $2,737 | $152 |
| Long return visit (40+ min) | 11 | $2,502 | $179 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 18 | $91 | $5 |
2020: 17 services
| Return visit (30+ min) | 242 | $32,673 | $97 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 91 | $20,750 | $228 |
| New patient visit (45+ min) | 71 | $10,736 | $151 |
| Biopsy of large bowel using a flexible endoscope | 85 | $10,326 | $121 |
| Short return visit (20+ min) | 138 | $10,320 | $66 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 102 | $9,126 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $8,486 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 48 | $7,360 | $66 |
| New patient visit (30+ min) | 57 | $5,482 | $96 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 21 | $4,531 | $216 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,440 | $185 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 18 | $3,777 | $210 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,906 | $121 |
| Long return visit (40+ min) | 20 | $2,576 | $129 |
| New patient visit (15+ min) | 33 | $1,785 | $54 |
| Telephone medical discussion with physician, 11-20 minutes | 23 | $1,754 | $73 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 27 | $138 | $4 |
2019: 15 services
| Return visit (30+ min) | 313 | $46,873 | $96 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 111 | $25,490 | $224 |
| Short return visit (20+ min) | 189 | $12,823 | $63 |
| New patient visit (45+ min) | 90 | $12,818 | $142 |
| Biopsy of large bowel using a flexible endoscope | 95 | $12,714 | $134 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 143 | $12,161 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $9,840 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 56 | $7,279 | $66 |
| New patient visit (30+ min) | 80 | $7,229 | $90 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 27 | $5,764 | $213 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 26 | $5,448 | $210 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,695 | $174 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $3,536 | $122 |
| New patient visit (15+ min) | 56 | $3,457 | $62 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 64 | $292 | $5 |
2018: 19 services
| Return visit (30+ min) | 242 | $36,729 | $91 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 78 | $17,268 | $221 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 76 | $15,183 | $63 |
| Short return visit (20+ min) | 194 | $12,833 | $58 |
| New patient visit (45+ min) | 63 | $8,894 | $141 |
| New patient visit (30+ min) | 97 | $8,402 | $87 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 82 | $7,807 | $93 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 36 | $7,462 | $207 |
| Biopsy of large bowel using a flexible endoscope | 60 | $7,093 | $118 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 31 | $6,331 | $204 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 48 | $5,983 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $5,123 | $90 |
| Biopsy of large bowel using a flexible endoscope | 37 | $4,790 | $129 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 37 | $3,255 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,969 | $175 |
| New patient visit (15+ min) | 40 | $2,647 | $66 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 11 | $2,245 | $204 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 42 | $194 | $5 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 12 | $46 | $4 |
2017: 15 services
| Return visit (30+ min) | 241 | $38,772 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 84 | $18,849 | $63 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 75 | $16,596 | $221 |
| Short return visit (20+ min) | 186 | $13,916 | $60 |
| Biopsy of large bowel using a flexible endoscope | 98 | $11,761 | $120 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 125 | $11,218 | $88 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 80 | $10,850 | $119 |
| New patient visit (30+ min) | 84 | $7,417 | $88 |
| New patient visit (45+ min) | 39 | $5,554 | $142 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 25 | $4,721 | $189 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $3,010 | $177 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $2,830 | $91 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 12 | $2,486 | $207 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | $2,039 | $102 |
| New patient visit (15+ min) | 21 | $1,334 | $64 |
2016: 13 services
| Return visit (30+ min) | 273 | $43,423 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 112 | $26,767 | $62 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 75 | $17,208 | $229 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 97 | $13,031 | $115 |
| Biopsy of large bowel using a flexible endoscope | 106 | $12,802 | $121 |
| Short return visit (20+ min) | 182 | $12,646 | $61 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 113 | $10,934 | $96 |
| New patient visit (45+ min) | 40 | $5,072 | $127 |
| New patient visit (30+ min) | 51 | $4,438 | $87 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 27 | $3,166 | $113 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 14 | $2,622 | $187 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,143 | $89 |
| New patient visit (15+ min) | 17 | $1,045 | $61 |
2015: 13 services
| Return visit (30+ min) | 250 | $39,931 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 140 | $32,710 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 102 | $14,244 | $118 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 53 | $13,727 | $259 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 122 | $13,472 | $110 |
| Biopsy of large bowel using a flexible endoscope | 63 | $10,129 | $158 |
| Short return visit (20+ min) | 143 | $9,593 | $58 |
| New patient visit (45+ min) | 48 | $6,738 | $140 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $5,472 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $4,012 | $174 |
| New patient visit (30+ min) | 43 | $3,766 | $88 |
| Diagnostic exam of large bowel using a flexible endoscope | 23 | $3,559 | $155 |
| New patient visit (15+ min) | 29 | $1,696 | $58 |
2014: 13 services
| Return visit (30+ min) | 256 | $47,232 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 146 | $34,225 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 117 | $15,719 | $116 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 133 | $13,942 | $102 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 52 | $13,915 | $263 |
| Short return visit (20+ min) | 146 | $10,836 | $59 |
| Biopsy of large bowel using a flexible endoscope | 82 | $10,769 | $131 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $8,393 | $89 |
| Diagnostic exam of large bowel using a flexible endoscope | 25 | $4,348 | $174 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,345 | $174 |
| New patient visit (45+ min) | 25 | $3,540 | $142 |
| New patient visit (30+ min) | 34 | $3,147 | $93 |
| New patient visit (15+ min) | 20 | $1,230 | $61 |
2013: 15 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 179 | $42,817 | $60 |
| Return visit (30+ min) | 218 | $40,688 | $91 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 140 | $16,484 | $115 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 115 | $15,079 | $115 |
| Short return visit (20+ min) | 180 | $14,927 | $60 |
| Biopsy of large bowel using a flexible endoscope | 93 | $14,802 | $159 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 40 | $10,531 | $263 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 59 | $9,114 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $8,328 | $167 |
| New patient visit (30+ min) | 100 | $7,479 | $75 |
| Diagnostic exam of large bowel using a flexible endoscope | 35 | $6,400 | $183 |
| New patient visit (45+ min) | 27 | $3,915 | $145 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 17 | $3,861 | $227 |
| New patient visit (15+ min) | 36 | $1,968 | $55 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 12 | $1,341 | $112 |
Drugs they prescribed that Part D paid
$324,077
Pharmacies billed $324,077 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,891) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
1,570 generic and 321 brand-name prescriptions · $324,077 in drug cost · 74 antibiotic prescriptions to 37 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Linzess | 75 | $97,081 | $1,294 |
| Mesalamine | 59 | $32,389 | $549 |
| Creon | 22 | $30,292 | $1,377 |
| Dexlansoprazole Dr | 40 | $14,017 | $350 |
| Pantoprazole | 728 | $10,833 | $15 |
See all 25 drugs
| Linzess | 75 | $97,081 | $1,294 |
| Mesalamine | 59 | $32,389 | $549 |
| Creon | 22 | $30,292 | $1,377 |
| Dexlansoprazole Dr | 40 | $14,017 | $350 |
| Pantoprazole | 728 | $10,833 | $15 |
| Sod Sulf-Potass Sulf-Mag Sulf | 115 | $7,482 | $65 |
| Colesevelam | 35 | $7,303 | $209 |
| Lubiprostone | 28 | $7,157 | $256 |
| Lansoprazole | 22 | $5,298 | $241 |
| Suflave | 39 | $4,796 | $123 |
| Mesalamine Er | 25 | $4,515 | $181 |
| Omeprazole | 212 | $3,255 | $15 |
| Plenvu | 20 | $3,097 | $155 |
| Sucralfate | 39 | $2,929 | $75 |
| Balsalazide Disodium | 17 | $2,666 | $157 |
| Mesalamine Dr | 11 | $1,933 | $176 |
| Misoprostol | 26 | $1,790 | $69 |
| Esomeprazole Magnesium | 31 | $1,180 | $38 |
| Budesonide Dr | 20 | $788 | $39 |
| Ondansetron Odt | 20 | $534 | $27 |
| Amoxicillin-Clavulanate Potass | 39 | $292 | $7 |
| Ondansetron | 36 | $280 | $8 |
| Famotidine | 32 | $265 | $8 |
| Dicyclomine | 13 | $192 | $15 |
| Metoclopramide | 11 | $49 | $4 |
Year by year
| 2024 | 1,891 | 609 | 0% (0) | 17% | $324,077 |
| 2023 | 1,807 | 555 | 0% (0) | None | $345,583 |
| 2022 | 1,833 | 506 | 0% (0) | None | $419,370 |
| 2021 | 1,757 | 515 | 0% (0) | 27% | $383,855 |
| 2020 | 1,691 | 484 | 0% (0) | 25% | $353,383 |
| 2019 | 1,899 | 471 | None | 27% | $459,461 |
| 2018 | 1,702 | 413 | 0% (0) | 29% | $525,637 |
| 2017 | 1,824 | 394 | None | 29% | $429,377 |
| 2016 | 1,770 | 380 | 0% (0) | 29% | $593,787 |
| 2015 | 1,607 | 322 | 0% (0) | 33% | $269,177 |
| 2014 | 1,513 | 288 | None | 33% | $197,066 |
| 2013 | 1,298 | 292 | None | 37% | $171,635 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 26 drugs
| Linzess | 54 | $74,480 | $1,379 |
| Creon | 24 | $36,174 | $1,507 |
| Dexlansoprazole Dr | 57 | $30,552 | $536 |
| Mesalamine | 44 | $27,494 | $625 |
| Lubiprostone | 46 | $11,796 | $256 |
| Pantoprazole | 680 | $11,442 | $17 |
| Colesevelam | 34 | $10,097 | $297 |
| Plenvu | 56 | $8,255 | $147 |
| Dexilant | 16 | $7,848 | $491 |
| Mesalamine Er | 14 | $6,696 | $478 |
| Lansoprazole | 25 | $5,809 | $232 |
| Balsalazide Disodium | 18 | $5,542 | $308 |
| Omeprazole | 214 | $4,877 | $23 |
| Sod Sulf-Potass Sulf-Mag Sulf | 64 | $4,872 | $76 |
| Sucralfate | 41 | $3,381 | $82 |
| Suflave | 15 | $1,993 | $133 |
| Misoprostol | 21 | $1,812 | $86 |
| Esomeprazole Magnesium | 29 | $1,611 | $56 |
| Amoxicillin-Clavulanate Potass | 54 | $608 | $11 |
| Ondansetron Odt | 17 | $536 | $32 |
| Diphenoxylate-Atropine | 11 | $361 | $33 |
| Dicyclomine | 23 | $336 | $15 |
| Famotidine | 18 | $219 | $12 |
| Ondansetron | 22 | $216 | $10 |
| Gavilyte-G | 13 | $204 | $16 |
| Lactulose | 11 | $155 | $14 |
2022: 30 drugs
| Linzess | 47 | $59,091 | $1,257 |
| Creon | 29 | $46,693 | $1,610 |
| Zenpep | 17 | $46,152 | $2,715 |
| Dexilant | 60 | $37,216 | $620 |
| Mesalamine | 44 | $30,317 | $689 |
| Dexlansoprazole Dr | 25 | $17,143 | $686 |
| Trulance | 11 | $15,636 | $1,421 |
| Lubiprostone | 23 | $13,665 | $594 |
| Mesalamine Er | 17 | $13,439 | $791 |
| Pantoprazole | 687 | $12,458 | $18 |
| Colesevelam | 35 | $9,003 | $257 |
| Amitiza | 22 | $8,886 | $404 |
| Plenvu | 49 | $6,687 | $136 |
| Balsalazide Disodium | 26 | $5,825 | $224 |
| Suprep | 46 | $5,248 | $114 |
| Omeprazole | 225 | $4,125 | $18 |
| Sucralfate | 52 | $2,643 | $51 |
| Cholestyramine | 17 | $2,157 | $127 |
| Misoprostol | 21 | $2,110 | $100 |
| Esomeprazole Magnesium | 34 | $997 | $29 |
| Ondansetron | 30 | $905 | $30 |
| Lansoprazole | 24 | $771 | $32 |
| Dicyclomine | 23 | $629 | $27 |
| Diphenoxylate-Atropine | 15 | $621 | $41 |
| Amoxicillin-Clavulanate Potass | 42 | $526 | $13 |
| Ondansetron Odt | 14 | $384 | $27 |
| Famotidine | 11 | $342 | $31 |
| Metronidazole | 12 | $206 | $17 |
| Ciprofloxacin | 13 | $117 | $9 |
| Prochlorperazine Maleate | 20 | $0 | $0 |
2021: 29 drugs
| Dexilant | 111 | $68,923 | $621 |
| Linzess | 58 | $65,134 | $1,123 |
| Creon | 39 | $50,626 | $1,298 |
| Mesalamine | 40 | $31,994 | $800 |
| Mesalamine Er | 17 | $13,362 | $786 |
| Pantoprazole | 593 | $12,839 | $22 |
| Amitiza | 24 | $10,574 | $441 |
| Colesevelam | 48 | $10,458 | $218 |
| Plenvu | 77 | $9,861 | $128 |
| Lubiprostone | 17 | $8,876 | $522 |
| Suprep | 33 | $3,653 | $111 |
| Omeprazole | 191 | $3,587 | $19 |
| Mercaptopurine | 12 | $3,039 | $253 |
| Esomeprazole Magnesium | 33 | $2,711 | $82 |
| Cholestyramine | 22 | $2,598 | $118 |
| Sucralfate | 45 | $2,390 | $53 |
| Budesonide Dr | 16 | $1,453 | $91 |
| Ondansetron | 24 | $958 | $40 |
| Diphenoxylate-Atropine | 20 | $814 | $41 |
| Lansoprazole | 19 | $710 | $37 |
| Dicyclomine | 20 | $518 | $26 |
| Misoprostol | 12 | $420 | $35 |
| Amoxicillin-Clavulanate Potass | 34 | $331 | $10 |
| Famotidine | 17 | $270 | $16 |
| Metronidazole | 15 | $237 | $16 |
| Sodium Chloride | 15 | $220 | $15 |
| Amoxicillin | 14 | $108 | $8 |
| Cephalexin | 13 | $71 | $5 |
| Prochlorperazine Maleate | 12 | $0 | $0 |
2020: 26 drugs
| Creon | 38 | $57,900 | $1,524 |
| Dexilant | 82 | $53,958 | $658 |
| Linzess | 34 | $39,968 | $1,176 |
| Mesalamine | 37 | $28,037 | $758 |
| Mesalamine Er | 27 | $19,394 | $718 |
| Amitiza | 34 | $18,990 | $559 |
| Colesevelam | 60 | $18,350 | $306 |
| Pantoprazole | 565 | $10,827 | $19 |
| Suprep | 99 | $10,299 | $104 |
| Entecavir | 16 | $9,549 | $597 |
| Motegrity | 11 | $5,077 | $462 |
| Mercaptopurine | 14 | $3,968 | $283 |
| Omeprazole | 212 | $3,248 | $15 |
| Sucralfate | 50 | $2,973 | $59 |
| Esomeprazole Magnesium | 32 | $2,251 | $70 |
| Cholestyramine | 11 | $2,239 | $204 |
| Plenvu | 16 | $1,916 | $120 |
| Misoprostol | 14 | $807 | $58 |
| Dicyclomine | 30 | $653 | $22 |
| Lansoprazole | 20 | $630 | $31 |
| Diphenoxylate-Atropine | 13 | $600 | $46 |
| Ondansetron | 12 | $493 | $41 |
| Famotidine | 18 | $287 | $16 |
| Amoxicillin-Clavulanate Potass | 31 | $279 | $9 |
| Metronidazole | 18 | $245 | $14 |
| Metoclopramide | 11 | $201 | $18 |
2019: 28 drugs
| Dexilant | 88 | $58,049 | $660 |
| Mesalamine | 51 | $45,487 | $892 |
| Linzess | 45 | $41,572 | $924 |
| Creon | 28 | $40,926 | $1,462 |
| Xifaxan | 15 | $27,355 | $1,824 |
| Apriso | 37 | $24,884 | $673 |
| Colesevelam | 51 | $15,868 | $311 |
| Amitiza | 32 | $15,394 | $481 |
| Welchol | 21 | $10,852 | $517 |
| Pantoprazole | 606 | $9,910 | $16 |
| Suprep | 91 | $9,130 | $100 |
| Omeprazole | 237 | $4,641 | $20 |
| Budesonide Ec | 11 | $3,873 | $352 |
| Esomeprazole Magnesium | 54 | $2,735 | $51 |
| Misoprostol | 25 | $2,625 | $105 |
| Cholestyramine | 15 | $2,020 | $135 |
| Sucralfate | 50 | $1,638 | $33 |
| Lansoprazole | 15 | $1,123 | $75 |
| Dicyclomine | 26 | $572 | $22 |
| Ursodiol | 12 | $561 | $47 |
| Amoxicillin-Clavulanate Potass | 35 | $436 | $12 |
| Ranitidine | 18 | $346 | $19 |
| Metronidazole | 19 | $308 | $16 |
| Prochlorperazine Maleate | 21 | $275 | $13 |
| Gavilyte-G | 11 | $159 | $14 |
| Famotidine | 20 | $116 | $6 |
| Ciprofloxacin | 11 | $97 | $9 |
| Prednisone | 13 | $33 | $3 |
2018: 31 drugs
| Creon | 32 | $67,919 | $2,122 |
| Dexilant | 76 | $48,497 | $638 |
| Mesalamine | 43 | $32,727 | $761 |
| Linzess | 27 | $26,692 | $989 |
| Entecavir | 23 | $20,396 | $887 |
| Apriso | 40 | $20,080 | $502 |
| Welchol | 56 | $18,985 | $339 |
| Lialda | 16 | $17,810 | $1,113 |
| Amitiza | 27 | $12,213 | $452 |
| Budesonide Ec | 12 | $7,478 | $623 |
| Pantoprazole | 511 | $7,351 | $14 |
| Suprep | 73 | $6,676 | $91 |
| Colesevelam | 19 | $4,938 | $260 |
| Esomeprazole Magnesium | 35 | $4,498 | $129 |
| Omeprazole | 243 | $3,839 | $16 |
| Ursodiol | 14 | $3,302 | $236 |
| Cholestyramine | 14 | $1,389 | $99 |
| Mercaptopurine | 13 | $1,373 | $106 |
| Lansoprazole | 14 | $1,204 | $86 |
| Sucralfate | 37 | $1,179 | $32 |
| Misoprostol | 16 | $1,049 | $66 |
| Polyethylene Glycol 3350 | 33 | $836 | $25 |
| Amoxicillin-Clavulanate Potass | 21 | $294 | $14 |
| Ranitidine | 13 | $250 | $19 |
| Metronidazole | 15 | $249 | $17 |
| Ondansetron Odt | 23 | $233 | $10 |
| Ciprofloxacin | 18 | $158 | $9 |
| Dicyclomine | 11 | $136 | $12 |
| Famotidine | 13 | $112 | $9 |
| Ondansetron | 13 | $91 | $7 |
| Prednisone | 19 | $88 | $5 |
2017: 26 drugs
| Creon | 34 | $70,582 | $2,076 |
| Dexilant | 106 | $47,390 | $447 |
| Lialda | 28 | $29,929 | $1,069 |
| Welchol | 68 | $26,447 | $389 |
| Linzess | 24 | $23,243 | $968 |
| Mesalamine | 28 | $23,113 | $825 |
| Entecavir | 22 | $19,285 | $877 |
| Apriso | 24 | $11,442 | $477 |
| Suprep | 96 | $8,426 | $88 |
| Amitiza | 22 | $7,727 | $351 |
| Carafate | 21 | $7,722 | $368 |
| Pantoprazole | 574 | $7,662 | $13 |
| Esomeprazole Magnesium | 52 | $7,641 | $147 |
| Erythromycin | 16 | $4,622 | $289 |
| Omeprazole | 268 | $3,292 | $12 |
| Mercaptopurine | 16 | $1,609 | $101 |
| Lansoprazole | 28 | $1,314 | $47 |
| Polyethylene Glycol 3350 | 32 | $789 | $25 |
| Spironolactone | 20 | $739 | $37 |
| Sucralfate | 34 | $521 | $15 |
| Ondansetron Odt | 21 | $216 | $10 |
| Amoxicillin-Clavulanate Potass | 19 | $204 | $11 |
| Furosemide | 17 | $199 | $12 |
| Ciprofloxacin | 16 | $137 | $9 |
| Amitriptyline | 12 | $85 | $7 |
| Famotidine | 13 | $73 | $6 |
2016: 28 drugs
| Creon | 32 | $59,315 | $1,854 |
| Dexilant | 109 | $41,215 | $378 |
| Welchol | 93 | $37,459 | $403 |
| Entecavir | 25 | $26,203 | $1,048 |
| Lialda | 21 | $20,125 | $958 |
| Xifaxan | 12 | $15,491 | $1,291 |
| Asacol Hd | 11 | $15,380 | $1,398 |
| Amitiza | 43 | $13,716 | $319 |
| Esomeprazole Magnesium | 24 | $8,325 | $347 |
| Suprep | 87 | $7,126 | $82 |
| Mesalamine | 12 | $7,110 | $592 |
| Linzess | 11 | $6,491 | $590 |
| Budesonide Ec | 12 | $6,440 | $537 |
| Pantoprazole | 488 | $5,421 | $11 |
| Omeprazole | 309 | $3,596 | $12 |
| Mercaptopurine | 20 | $2,665 | $133 |
| Carafate | 12 | $1,930 | $161 |
| Lansoprazole | 43 | $1,886 | $44 |
| Cholestyramine | 11 | $1,639 | $149 |
| Sucralfate | 51 | $949 | $19 |
| Diphenoxylate-Atropine | 18 | $723 | $40 |
| Polyethylene Glycol 3350 | 28 | $662 | $24 |
| Ciprofloxacin | 23 | $560 | $24 |
| Spironolactone | 12 | $545 | $45 |
| Amoxicillin-Clavulanate Potass | 31 | $457 | $15 |
| Metronidazole | 19 | $377 | $20 |
| Amitriptyline | 13 | $99 | $8 |
| Furosemide | 15 | $79 | $5 |
2015: 28 drugs
| Creon | 29 | $46,263 | $1,595 |
| Dexilant | 119 | $37,402 | $314 |
| Asacol Hd | 29 | $30,841 | $1,063 |
| Welchol | 99 | $30,230 | $305 |
| Entecavir | 20 | $20,854 | $1,043 |
| Nexium | 55 | $18,247 | $332 |
| Lialda | 16 | $14,133 | $883 |
| Amitiza | 28 | $9,444 | $337 |
| Budesonide Ec | 15 | $8,449 | $563 |
| Pantoprazole | 356 | $3,907 | $11 |
| Omeprazole | 316 | $3,851 | $12 |
| Linzess | 11 | $3,690 | $335 |
| Carafate | 14 | $2,564 | $183 |
| Lansoprazole | 42 | $2,451 | $58 |
| Mercaptopurine | 18 | $2,196 | $122 |
| Suprep | 20 | $1,624 | $81 |
| Sucralfate | 50 | $1,120 | $22 |
| Polyethylene Glycol 3350 | 33 | $1,026 | $31 |
| Diphenoxylate-Atropine | 21 | $680 | $32 |
| Gavilyte-N | 32 | $627 | $20 |
| Propranolol Hcl Er | 11 | $566 | $51 |
| Spironolactone | 13 | $543 | $42 |
| Metronidazole | 25 | $484 | $19 |
| Amoxicillin-Clavulanate Potass | 23 | $314 | $14 |
| Peg 3350-Electrolyte | 17 | $294 | $17 |
| Metoclopramide | 12 | $143 | $12 |
| Amitriptyline | 12 | $127 | $11 |
| Furosemide | 12 | $96 | $8 |
2014: 34 drugs
| Dexilant | 123 | $33,127 | $269 |
| Nexium | 66 | $21,959 | $333 |
| Asacol Hd | 32 | $20,245 | $633 |
| Creon | 20 | $20,051 | $1,003 |
| Welchol | 70 | $18,310 | $262 |
| Budesonide Ec | 18 | $9,902 | $550 |
| Lialda | 12 | $8,405 | $700 |
| Linzess | 20 | $5,889 | $294 |
| Octreotide Acetate | 14 | $4,869 | $348 |
| Omeprazole | 356 | $4,261 | $12 |
| Carafate | 25 | $3,527 | $141 |
| Lansoprazole | 51 | $3,470 | $68 |
| Amitiza | 11 | $3,330 | $303 |
| Pantoprazole | 243 | $3,258 | $13 |
| Prepopik | 16 | $1,328 | $83 |
| Sucralfate | 42 | $1,209 | $29 |
| Cholestyramine | 14 | $1,100 | $79 |
| Mercaptopurine | 16 | $940 | $59 |
| Polyethylene Glycol 3350 | 23 | $927 | $40 |
| Propranolol Hcl Er | 12 | $640 | $53 |
| Gavilyte-N | 30 | $575 | $19 |
| Peg-3350 | 20 | $366 | $18 |
| Amox Tr-Potassium Clavulanate | 20 | $359 | $18 |
| Spironolactone | 12 | $350 | $29 |
| Metoclopramide | 31 | $261 | $8 |
| Metronidazole | 12 | $246 | $21 |
| Lactulose | 12 | $243 | $20 |
| Dicyclomine | 12 | $169 | $14 |
| Diphenoxylate-Atropine | 15 | $150 | $10 |
| Proctozone-Hc | 13 | $149 | $11 |
| Furosemide | 15 | $96 | $6 |
| Amitriptyline | 12 | $80 | $7 |
| Generlac | 11 | $75 | $7 |
| Ciprofloxacin | 13 | $73 | $6 |
2013: 28 drugs
| Nexium | 92 | $25,940 | $282 |
| Creon | 19 | $21,636 | $1,139 |
| Dexilant | 99 | $21,530 | $217 |
| Budesonide Ec | 17 | $13,633 | $802 |
| Asacol Hd | 15 | $9,153 | $610 |
| Welchol | 36 | $7,983 | $222 |
| Omeprazole | 323 | $4,686 | $15 |
| Lansoprazole | 35 | $3,498 | $100 |
| Pantoprazole | 150 | $2,877 | $19 |
| Linzess | 11 | $2,413 | $219 |
| Halflytely-Bisacodyl | 20 | $1,345 | $67 |
| Suprep | 16 | $1,159 | $72 |
| Moviprep | 16 | $1,135 | $71 |
| Cholestyramine | 15 | $931 | $62 |
| Misoprostol | 12 | $878 | $73 |
| Lactulose | 27 | $813 | $30 |
| Sucralfate | 26 | $770 | $30 |
| Polyethylene Glycol 3350 | 28 | $749 | $27 |
| Metronidazole | 25 | $549 | $22 |
| Peg-3350 With Flavor Packs | 18 | $319 | $18 |
| Gavilyte-N | 17 | $307 | $18 |
| Spironolactone | 12 | $305 | $25 |
| Diphenoxylate-Atropine | 19 | $191 | $10 |
| Metoclopramide | 25 | $190 | $8 |
| Ciprofloxacin | 12 | $88 | $7 |
| Zolpidem | 18 | $80 | $4 |
| Furosemide | 18 | $72 | $4 |
| Amitriptyline | 11 | $22 | $2 |
Money from drug and device companies
$29 in 2025
| 2025 | 1 | 1 | None | $29 |
| 2024 | 2 | 25 | None | $284 |
| 2023 | 5 | 27 | None | $358 |
| 2022 | 5 | 93 | None | $1,373 |
| 2021 | 3 | 112 | None | $1,618 |
| 2020 | 3 | 45 | None | $518 |
| 2019 | 3 | 42 | None | $383 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Mauna Kea Technologies | None | $29 | 1 payment
|
See the published payment
| Mauna Kea Technologies | Meals · 2025-07-21 | None | $29 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $284
| Abbvie | Rinvoq | $252 | 23 payments
|
| Celgene | Zeposia | $32 | 2 payments
|
2023: $358
| Abbvie | Viberzi | $203 | 18 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $87 | 5 payments
|
| Celgene | Zeposia | $29 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $20 | 1 payment
|
| Janssen Biotech | Remicade | $20 | 1 payment
|
2022: $1,373
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $712 | 47 payments
|
| Abbvie | Rinvoq | $457 | 38 payments
|
| Janssen Biotech | Remicade | $97 | 4 payments
|
| Ardelyx | Ibsrela | $63 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $45 | 2 payments
|
2021: $1,618
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $830 | 52 payments
|
| AbbVie | Humira | $637 | 47 payments
|
| Nestle HealthCare Nutrition | Zenpep | $151 | 13 payments
|
2020: $518
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $344 | 31 payments
|
| AbbVie | Humira | $148 | 12 payments
|
| Nestle HealthCare Nutrition | Zenpep | $27 | 2 payments
|
2019: $383
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $233 | 26 payments
|
| Ferring Pharmaceuticals | Clenpiq | $129 | 13 payments
|
| QOL Medical | Sucraid | $21 | 3 payments
|
Professional record
- NPI
- 1841256963
- Licence
- CA A95045California A95045: Current · expires 2027-11-30
- Trained
- New York Medical College, 2000
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 1133 E Stanley Blvd, Suite 207, Livermore, CA, 94550
- NPI first listed
- 2006-04-26
- NPI last updated
- 2008-04-08
This is when the NPI record was last certified, not a medical board exam.